TLR-4, a bacterial sensor whose activation stimulates NF-κB signaling and inflammatory cytokine production, has been associated with the risk of developing gastrointestinal toxicity during irinotecan treatment, likely related to intestinal mucosal damage and associated infections [125]. The gene discussed is NFKB1; the disease is infection.